Nuveen Asset Management, LLC Sarepta Therapeutics, Inc. Transaction History
Nuveen Asset Management, LLC
- $329 Billion
- Q1 2024
A detailed history of Nuveen Asset Management, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 542,575 shares of SRPT stock, worth $83.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
542,575
Previous 533,257
1.75%
Holding current value
$83.1 Million
Previous $51.4 Million
36.6%
% of portfolio
0.02%
Previous 0.02%
Shares
26 transactions
Others Institutions Holding SRPT
# of Institutions
470Shares Held
79.3MCall Options Held
4.23MPut Options Held
1.21M-
Vanguard Group Inc Valley Forge, PA8.8MShares$1.35 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.96MShares$913 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.89MShares$749 Million0.36% of portfolio
-
Capital International Investors Los Angeles, CA4.82MShares$738 Million0.13% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.34MShares$665 Million6.78% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $13.4B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...